- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05454423
Effect of Aquatic Exercise and Traditional Physical Therapy on Gout in Hypertensive Menopausal Women With Hyperuricemia
Study Overview
Status
Conditions
Detailed Description
Menopause is defined as a point in time 12 months after a woman's last period. During the menopausal transition, changes in estrogen and progesterone levels affect not only vasomotor symptoms, sexual dysfunction, osteoporosis, and cardiovascular disease (CVD), but also uric acid level1. An association between menopausal status and hyperuricemia has been previously examined. A study using the Third National Health and Nutrition Examination Survey showed a positive and independent association of menopause with hyperuricemia and gout. It's believed that estrogen has a protective effect that is removed at menopause, thus accounting for the rise in gout in women who are postmenopausal2.
Hyperuricemia is a common biochemical abnormality resulting from excessive uric acid production or impaired clearance of uric acid. Although its pathophysiology is not fully understood, genetic, comorbid disease-related, and environmental (drug, diet, and toxic exposure-induced) factors are involved in hyperuricemia3.
Gout is a multifactorial disease caused by hyperuricemia and monosodium urate crystals deposition. Pain typically comes on rapidly, reaching maximal intensity in less than 12 hours. The joint at the base of the big toe is affected in about half of cases4.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ahmed A Abd El Rahim, PHD
- Phone Number: 01006281510
- Email: toota_1234@yahoo.com
Study Contact Backup
- Name: Mohamed Mabrouk, PHD
- Phone Number: 01155555088
- Email: Mohamed.hypa@deraya.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
100 patients with gout
- Age between 45 -65 years
- Cooperative patient.
- A physician referred all patients with the diagnosis of gout
Exclusion Criteria:
- history of kidney disease such as chronic kidney disease, Cancer patients. Smokers Patients with chronic heart disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: aquatic exercise + Traditional physical therapy + anti-hyperuricemia medication
consisted of 50 Patients received aquatic exercise and Traditional physical therapy in addition to anti-hyperuricemia medication (a potent purine xanthine oxidase (XO) inhibitor) in therapeutic dose.
|
-Aquatic exercises: At the beginning of the exercises, aquatic exercises technique was educated to the participants out of water. Then, the aquatic exercises were conducted in a chest warm pool (28-30°C) for 30 minutes, three sessions a week for eight weeks. -Traditional physical therapy programs : which included using hot packs (20 minutes), ultrasound (5 minutes), and electrotherapy using TENS (15 minutes) in addition to stretching exercises for the calf, hamstring muscles and big toes and strengthening exercises for the quadriceps muscles for 30 minutes". The stretching exercises were performed in 3 weekly sessions over 8 weeks, each with a 30 second holding and a 30-second relaxation repeated three times. One group of strengthening exercises consisted of 10 repeats with a 5 second holding |
|
Placebo Comparator: traditional physical therapy + anti-hyperuricemia medication
consisted of 50 Patients received traditional physical therapy in addition to anti-hyperuricemia medication (a potent purine xanthine oxidase (XO) inhibitor) in therapeutic dose.
|
traditional physical therapy programs, which included using hot packs (20 minutes), ultrasound (5 minutes), and electrotherapy using TENS (15 minutes) in addition to stretching exercises for the calf, hamstring muscles and big toes and strengthening exercises for the quadriceps muscles for 30 minutes".
The stretching exercises were performed in 3 weekly sessions over 8 weeks, each with a 30 second holding and a 30 second relaxation repeated three times.
One group of strengthening exercises consisted of 10 repeats with a 5 second holding17.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Serum uric acid level before and after treatment for both groups (A and B): Table 2: Mean values for Serum uric acid level before and after treatment for both groups (A and B).
Time Frame: 2 week before and 2 week after
|
a sample of blood was used to assess the level of uric acid in the blood for both groups A & B before and after treatment
|
2 week before and 2 week after
|
|
Visual analogue scale before and after treatment for both groups (A and B): Chicago, Illinois, USA). The P-value is the degree of significance. A P value less than or equal to 0.05 was considered to be significant.
Time Frame: 2 week before and 2 week after
|
consists of a straight line with the endpoints defining extreme limits such as 'no pain at all' and 'pain as bad as it could be.
The patient was asked to mark her pain level on the line between the two endpoints.
The distance between 'no pain at all' and the mark then defines the subject's pain intensity .
|
2 week before and 2 week after
|
|
The Borg Rating of Perceived Exertion (RPE) scale
Time Frame: 2 week before and 2 week after
|
will be used to measure the level of exertional effort for both groups A & B before and after treatment
|
2 week before and 2 week after
|
|
Digital blood pressure monitor
Time Frame: 2 week before and 2 week after
|
It measures blood pressure (systolic & diastolic) quickly, is easy to use, reliable, and convenient to carry.
The monitor has a display that shows systolic blood pressure and diastolic blood pressure.
The machine comes with an arm cuff with an air tube and an air jack for connecting the cuff to the machine
|
2 week before and 2 week after
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Derby CA, Crawford SL, Pasternak RC, Sowers M, Sternfeld B, Matthews KA. Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation. Am J Epidemiol. 2009 Jun 1;169(11):1352-61. doi: 10.1093/aje/kwp043. Epub 2009 Apr 8.
- Richette P, Bardin T. Gout. Lancet. 2010 Jan 23;375(9711):318-28. doi: 10.1016/S0140-6736(09)60883-7. Epub 2009 Aug 17.
- Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016 Oct 22;388(10055):2039-2052. doi: 10.1016/S0140-6736(16)00346-9. Epub 2016 Apr 21.
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- A Eon gout
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gout
-
AmgenRecruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Atom Therapeutics Co., LtdRecruitingGout Flare | Acute Gouty Arthritis | Gout Flares | Acute Gout FlareChina, United States, Australia
-
Guangdong Hengqin Novagains Biopharmaceutical Co...Xiangbei Welman Pharmaceutical Co., Ltd; Guangzhou Xin-Chuangyi Biopharmaceutical...Not yet recruitingHyperuricemia With or Without GoutChina
-
Örebro University, SwedenRecruitingHyperuricemia With or Without GoutSweden
-
Guangdong Hengqin Novagains Biopharmaceutical Co...Xiangbei Welman Pharmaceutical Co., Ltd; Guangzhou Xin-Chuangyi Biopharmaceutical...Enrolling by invitationHyperuricemia With or Without GoutChina
-
SingHealth PolyclinicsNot yet recruitingGout Flare | Gout; Hyperuricemia | Gout ChronicSingapore
-
Atom Therapeutics Co., LtdCompletedGout | Gout Flares | Acute Gout FlareUnited States
-
Arthrosi TherapeuticsActive, not recruitingHyperuricemia | Gout | Uncontrolled Gout | Gouty Arthritis | Gout Chronic | Tophaceous Gout | Refractory GoutUnited States
-
Ai PengActive, not recruitingGout Flare | Intercritical Gout | Advanced Gout | Asymptomatic HyperuricemiaChina
Clinical Trials on the Aquatic exercises +Traditional physical therapy programs +anti-hyperuricemia medication
-
Cairo UniversityCompletedDiplegic Cerebral Palsy | Balance Board | Standing BalanceEgypt
-
Cairo UniversityDelta University for Science and TechnologyRecruitingStroke in Patients: New Tool to Evaluate the Impact in Their Life | Stroke ( 3 Months After Onset)Egypt
-
Jocelyn FitzgeraldTerminatedInterstitial Cystitis | Bladder Pain Syndrome | Levator SpasmUnited States